News
New FDA Covid-19 Policy Supports Vaccines for High-Risk Groups, More Clinical Trials for Others
In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid-19, the FDA said its policy will compel generation of more evidence for these groups.
Pfizer Inc. failed to convince advisers to the US Food and Drug Administration to support a dramatic expansion in the use of its prostate cancer drug, a setback ... The FDA isn’t required ...
Hosted on MSN2mon
Pfizer and other pandemic favorites in focus as FDA’s top vaccine regulator resignsHis resignation marks another setback for vaccine ... vaccines developed by Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) in 2020. In 2021, two top FDA officials at the ...
Nothing stopped red states from "challenging the scope of FDA’s authority or its decisionmaking" before Dobbs ruling, DOJ ...
The FDA has approved new versions of Pfizer ... for its candidate next year or in 2026, while Pfizer/BioNTech recently suffered a setback in a phase 3 trial that delayed their programme.
Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback